FDA approves Lilly’s Mounjaro to reduce cardiovascular risk in type 2 diabetes patients The U. S. Food and Drug Administration has approved Eli Lilly’s Mounjaro to minimise the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular. ..
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan